Disclaimer

The trademark information displayed on this page is public information and is provided for informational purposes only. This information may be incomplete, inaccurate, or outdated, and IndiaFilings does not guarantee its accuracy. IndiaFilings is an independent platform and is not associated, affiliated, or connected with any trademark listed in this database. We do not represent or speak on behalf of any such trademark. If you are trying to contact a specific trademark, please use their official channels. IndiaFilings cannot assist with queries directed at other companies.

CLINDATYL

Class 5Status: Accepted
Application Number5872100
Trademark Status
Accepted
Trademark Class5
Application Date2023-03-30
Proprietor NameM/S. NANDANI MEDICAL LABORATORIES PRIVATE LIMITED
Appropriate OfficeMUMBAI
StateMADHYA PRADESH
Trademark TypeWORD
User Details20/09/2020
Agent NameRIGHTWAY LEGAL SOLUTIONS & CO.[25010]
Agent AddressI-74,LIG COLONY, INDORE (M.P)-452007
Goods And Services Details[CLASS : 5] MEDICINAL & PHARMACEUTICAL PREPARATIONS INCLUDED IN CLASS 5.

Identical Trademarks

Similar trademarks found for this brand

1 found
BrandClassStatus
CLINDATYL5Accepted
Showing up to 6 identical trademarksView more on LEDGERS→

Trademark Protection

Automate the monitoring of your trademark application and filing of response to Government Objection or Hearing.

₹9,899+ GST

What's included:

✓
Brand Guard ( 1 application 1 class)
✓
Appointment of Lawyer
✓
Objection
✓
Hearing
✓
Infringement support (1)
✓
Power of Attorney (POA)

Frequently asked questions

Common questions about CLINDATYL.

What is the status of trademark application 5872100?
The current status of trademark application 5872100 for CLINDATYL is Accepted.
What is the trademark class of CLINDATYL?
CLINDATYL is registered under trademark class 5.
Who is the proprietor of CLINDATYL?
The proprietor of CLINDATYL is M/S. NANDANI MEDICAL LABORATORIES PRIVATE LIMITED.
When was trademark application 5872100 filed?
Trademark application 5872100 for CLINDATYL was filed on 2023-03-30.